Emergent BioSolutions Inc. (EBS)
EBS trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.91
-1.00% on the day
Market cap
$354.3M
Small cap
Revenue · 2025
$742.9M
-28.8% on 2024
Net income · 2025
$52.6M
7.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | EBS on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2006 |
| SEC CIK | 0001367644 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $742.9M |
| Net income | $52.6M |
| Operating income | $100.1M |
| Net margin | 7.1% |
| Operating margin | 13.5% |
| Revenue growth | -28.8% |
| Cash | $205.4M |
| Total assets | $1.3B |
| P/E (computed) | 6.7× |
| P/S (computed) | 0.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-08-07 |
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-14 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -2.3% |
| 1 month | +8.6% |
| 3 months | -10.1% |
| Year to date | -44.1% |
| 1 year | -25.7% |
| From 52-week high | -50.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IRD | Opus Genetics Inc. | $4.24 | -8.62% | $352.8M |
| RLMD | Relmada Therapeutics Inc. | $3.36 | -4.27% | $358.4M |
| ARCT | Arcturus Therapeutics Holdings Inc. | $12.03 | -4.60% | $341.9M |
| GALT | Galectin Therapeutics Inc. | $3.69 | -4.65% | $372.9M |
| ENTA | Enanta Pharmaceuticals Inc. | $11.52 | -6.34% | $335.5M |
| INDP | Indaptus Therapeutics Inc. | $2.39 | -2.05% | $318.4M |
| CTNM | Contineum Therapeutics Inc. | $8.42 | -1.69% | $316.8M |
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier